StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Kush Bohra

BUYGlenmark Pharmaceuticals
Glenmark Pharmaceuticals share price target & all analyst calls

byKush BohraHorizon: NA (inferred Swing (≤2wk))5 Oct 2026via NDTV Profit (Live)

Entry—Next open
Target₹2,320
Total upside —
Stop lossNot given
CMP₹2,2954h ago
ActiveNA+1.09%upside left 14d left
Follow Kush Bohra for new calls(35% target hit, 141 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alertsSee 88 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 5 Oct, 8:47 pm IST
8 supporting2 neutral2 opposing
Supports the BUY call (8)

Glenmark expects innovative drugs to drive higher revenue share: CMD Glenn Saldanha

NewsCnbc-Tv18·5 Oct · today

(opens in new tab)

Glenmark Pharma FY26 PAT Rises 30.1% to ₹13,620 Million; Q4 EBITDA Jumps to ₹9.4b

NewsGoogle News·27 Sept · 1w ago

(opens in new tab)

Glenmark Pharma gets EIR for Goa facility from US FDA

NewsGoogle News·23 Sept · 2w ago

(opens in new tab)

Glenmark Receives US FDA Inspection Report For Goa Facility; Shares Rise 0.28%

NewsGoogle News·23 Sept · 2w ago

(opens in new tab)

Glenmark Pharmaceuticals trades higher on getting EIR with VAI status for Goa facility

NewsGoogle News·23 Sept · 2w ago

(opens in new tab)
Neutral / worth noting (2)

Glenmark Pharmaceuticals (NSE: GLENMARK) U.S. FDA Compliance Update for Goa Facility

NewsGoogle News·23 Sept · 2w ago

(opens in new tab)

Glenmark transfers nebulizer brands to subsidiary for ₹223 Cr

NewsGoogle News·23 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (2)

MACD below its signal line — bearish momentum

Technicals · macd·5 Oct · today

Past week's volume 1.7× the 30-day average

Technicals · volume·5 Oct · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Kush Bohra

Every call and its outcome